Skip to the page

Data / Research funding / Zika Virus

Zika Virus: 74 NIH awards ($134.4M) to 48 organizations

74 NIH awards ($134.4M) in the NIH spending category Zika Virus, to 48 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.

SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.

Topic
NIH spending category

Awards

74 awards in the window.

AwardAgencyInstitute or divisionFiscal yearAmount in windowStartEndPrincipal investigatorSource
West African Center for Emerging Infectious DiseasesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$6,658,566June 9, 2020June 5, 2025WEAVER, SCOTT Creporter.nih.gov
Quanitifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$5,011,286April 1, 2020March 31, 2026VAZQUEZ PROKOPEC, GONZALO MARTINreporter.nih.gov
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease riskNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$4,905,886July 13, 2021April 30, 2027HARRIS, EVAreporter.nih.gov
Validating the Flavivirus Envelope Protein as an Antiviral TargetNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$3,735,490March 1, 2020February 28, 2026YANG, PRISCILLA LI-NINGreporter.nih.gov
Structure-based design of broad flavivirus immunogensNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$3,710,975September 24, 2021August 31, 2026LAI, JONATHAN R.reporter.nih.gov
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDSNIHNational Institute of Neurological Disorders and Stroke2021 to 2024$3,695,974May 1, 2021October 31, 2024CAIN, MATTHEW Dreporter.nih.gov
Neurodevelopment after postnatal Zika virus infection in infant macaquesNIHNational Institute of Neurological Disorders and Stroke2021 to 2025$3,679,627January 1, 2021November 30, 2026CHAHROUDI, ANN Mreporter.nih.gov
Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced IndividualsNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$3,665,742April 13, 2021March 31, 2027KREBS, SHELLY Jreporter.nih.gov
Development of a Replicon RNA-based Vaccine against Dengue and ZikaNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$3,590,945June 1, 2021May 31, 2026SHRESTA, SUJANreporter.nih.gov
Sample-to-Answer, Rapid, Multiplexed and PCR-Free Diagnostics of Arboviral Diseases in Resource Limited SettingsNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$3,579,220December 23, 2020November 30, 2026YANIK, AHMET ALIreporter.nih.gov
Maternal Antibody-Mediated Enhancement of Dengue PathogenesisNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$3,138,902March 5, 2021February 28, 2026SHRESTA, SUJANreporter.nih.gov
Early neural predictors and neuropathogenesis of sensorimotor neurodevelopmental deficits in macaque infants exposed to Zika virus in uteroNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$3,025,789June 1, 2020May 31, 2026MOHR, EMMA Lreporter.nih.gov
Understanding the mechanisms of antibody-mediated transcytosis of ZIKV within the placentaNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$3,021,123June 11, 2020May 31, 2026SUTHAR, MEHUL SHAMALreporter.nih.gov
Deciphering the Role of Chemokine Receptor CCR5 in Maternal Flavivirus InfectionsNIHNational Institute of Allergy and Infectious Diseases2025$3,021,038September 2, 2025August 31, 2029LIM, JEAN KYOUreporter.nih.gov
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1NIHNational Institute of Allergy and Infectious Diseases2022 to 2024$2,948,061January 21, 2019July 31, 2025FIKRIG, EROLreporter.nih.gov
Anchimerically Activatable Anti-Zika/Dengue ProTidesNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$2,946,770August 1, 2021July 31, 2026WAGNER, CARSTON R.reporter.nih.gov
Childhood Outcome After In Utero ZIKV ExposureNIHEunice Kennedy Shriver National Institute of Child Health & Human Development2021 to 2024$2,915,429September 10, 2020June 30, 2025MULKEY, SARAH BETHreporter.nih.gov
Dengue-Zika: Correlates of Cross-Protection in Non-Human PrimatesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$2,724,960January 9, 2020December 31, 2025SARIOL, CARLOS Areporter.nih.gov
Assessing desiccation tolerance's impact on Aedes aegypti midgut infectionNIHNational Institute of Allergy and Infectious Diseases2025$2,536,503September 8, 2025August 31, 2029DICKSON, LAURA Breporter.nih.gov
Zika virus nonstructural protein 5 inhibition of interferon signalingNIHNational Institute of Allergy and Infectious Diseases2023 to 2025$2,477,738August 21, 2023July 31, 2027EVANS, MATTHEW Jreporter.nih.gov
Flavivirus immunity in endemic and non-endemic human cohortsNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$2,322,225February 16, 2021January 31, 2027MESSER, WILLIAMreporter.nih.gov
Anti-flavivirus B cell response analysis to aid vaccine designNIHNational Institute of Allergy and Infectious Diseases2023 to 2025$2,304,231February 6, 2023January 31, 2028LI, YUXINGreporter.nih.gov
Development of Inhibitors Targeting Flavivirus MethyltransferaseNIHNational Institute of Allergy and Infectious Diseases2023 to 2025$2,302,146April 7, 2023March 31, 2028LI, HONGMINreporter.nih.gov
ANTIBODY-BASED PROTECTION AGAINST FLAVIVIRUSESNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$2,212,878September 15, 2007January 31, 2029DIAMOND, MICHAEL Sreporter.nih.gov
Probing Functional States and Inhibition of Flaviviral Proteases Using Nanopore TweezersNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$2,190,088June 10, 2021May 31, 2027CHEN, MINreporter.nih.gov
The paradox of flavivirus antigenic non-reciprocityNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$2,146,248July 24, 2024May 31, 2029FRIEDRICH, THOMAS C.reporter.nih.gov
Investigating astrocytic RIPK3 as a driver of protective neuroinflammation during viral encephalitisNIHNational Institute of Neurological Disorders and Stroke2021 to 2025$2,142,099February 15, 2021January 31, 2027DANIELS, BRIANreporter.nih.gov
Interplay between AMPK and Hippo Signaling Regulates Ocular Antiviral Response to Zika virus infectionNIHNational Eye Institute2021 to 2024$2,079,783January 1, 2021December 31, 2025ARUMUGASWAMI, VAITHILINGARAJAreporter.nih.gov
Role of microglia in neural infectionNIHNational Institute of Neurological Disorders and Stroke2022 to 2025$1,997,135January 15, 2022December 31, 2026WU, PINGreporter.nih.gov
Role of Zika virus (ZIKV) infection in glaucoma pathobiologyNIHNational Eye Institute2021 to 2025$1,980,186September 1, 2021August 31, 2027SINGH, PAWAN KUMARreporter.nih.gov
Mechanistic Insights into flavivirus NS5-mediated STAT2 SuppressionNIHNational Institute of Allergy and Infectious Diseases2021 to 2025$1,932,088March 15, 2021February 28, 2026HAI, RONGreporter.nih.gov
Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigationNIHNational Institute of General Medical Sciences2021 to 2025$1,886,759August 23, 2016May 31, 2026BEDFORD, TREVOR BCreporter.nih.gov
Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inferenceNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,862,316April 9, 2021March 31, 2026SUCHARD, MARC A.reporter.nih.gov
A novel strategy for vaccine-induced protection against maternal-to-fetal transmission of Zika virusNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$1,768,228June 7, 2024April 30, 2029SHRESTA, SUJANreporter.nih.gov
Impact of Zika Virus Infection on Fetal Innate and Adaptive ImmunityNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$1,692,705July 12, 2024May 31, 2029ADAMS WALDORF, KRISTINA M.reporter.nih.gov
Enhanced susceptibility to Zika virus during pregnancy: a role for maternal dengue antibodiesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,687,512September 17, 2020August 31, 2025LIM, JEAN KYOUreporter.nih.gov
Multiplex serological assays to support arbovirus diagnosis, surveillance and vaccinesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,654,516May 11, 2020April 30, 2025DESILVA, ARAVINDA M.reporter.nih.gov
A Novel Strategy for Generating Safe and Effective Flavivirus VaccinesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,606,114June 1, 2020May 31, 2026AUGUSTE, ALBERT J.reporter.nih.gov
Treating flaviviruses with mRNA-encoded Cas13NIHNational Institute of Allergy and Infectious Diseases2024 to 2025$1,562,785June 13, 2024May 31, 2029SANTANGELO, PHILIP Jreporter.nih.gov
Meningeal Immunity and Viral NeuropathogenesisNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$1,538,230August 16, 2024July 31, 2029DIAMOND, MICHAEL Sreporter.nih.gov
Mechanisms of tunneling nanotube formation by ZIKV NS1 in viral host interactions at the maternal-fetal interfaceNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$1,537,613December 1, 2023October 31, 2028JOSE, JOYCEreporter.nih.gov
Molecular mechanisms linking viral replication and neuropathogenesisNIHNational Institute of Allergy and Infectious Diseases2023 to 2025$1,506,928February 8, 2023January 31, 2028SHAH, PRIYA SHIRISHreporter.nih.gov
Multiplexed Detection of Mosquito-Borne Viruses at the Point-of-CareNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,482,375February 11, 2021January 31, 2026FAN, Z. HUGHreporter.nih.gov
How flaviviruses hijack a host transmembrane protein chaperone to promote viral infectionNIHNational Institute of General Medical Sciences2021 to 2024$1,424,560September 20, 2021July 31, 2025TAI, ANDREW W.reporter.nih.gov
Understanding mosquito movement and its relevance to control through genetic analysisNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,392,640September 21, 2020August 31, 2025MARSHALL, JOHN MACKYreporter.nih.gov
Long-term language outcomes in children with prenatal virus exposureNIHNational Institute on Deafness and Other Communication Disorders2024 to 2025$1,253,694April 1, 2024March 31, 2029HOOD, LINDA J.reporter.nih.gov
Clinical progression and predictors of outcomes in congenital Zika syndromeNIHEunice Kennedy Shriver National Institute of Child Health & Human Development2024 to 2025$1,248,888August 1, 2024April 30, 2029WHEELER, ANNE CAROLINEreporter.nih.gov
Gigapixel Next-Generation-Sequencing: An Ultra-Sensitive Diagnostic for Infections of the CNSNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$1,221,032November 1, 2023October 31, 2027ABATE, ADAM R.reporter.nih.gov
Implications of sequential bloodmeals on arbovirus transmission by mosquitoesNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$1,188,325May 12, 2020April 30, 2026BRACKNEY, DOUGLAS E.reporter.nih.gov
Development of a vaccination platform for emerging flavivirus infectionsNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$919,536November 4, 2021October 31, 2026BECKHAM, JOHN DAVIDreporter.nih.gov
Novel Aglains as Therapeutic Agents for Mosquito-borne ArbovirusesNIHNational Institute of Allergy and Infectious Diseases2025$808,919September 18, 2025August 31, 2030PORCO, JOHN A.reporter.nih.gov
Molecular mechanism of Zika virus-induced premature craniofacial suture closureNIHNational Institute of Dental & Craniofacial Research2024 to 2025$805,000January 1, 2024December 31, 2028CHEN, WEIQIANGreporter.nih.gov
A Novel T cell-based Vaccine to Prevent Dengue/Zika virus infectionNIHNational Institute of Allergy and Infectious Diseases2025$781,718June 1, 2025March 31, 2026QIAO, LIANGreporter.nih.gov
Defining Molecular Epitopes of Protective Antibodies to FlavivirusesNIHNational Institute of Allergy and Infectious Diseases2022 to 2025$780,940February 4, 2022January 31, 2027MARKMANN, ALENA JANDAreporter.nih.gov
Innate Immunity of Zika Virus Infection In Human Neural ProgenitorsNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$777,770April 16, 2020March 31, 2026STOKES, CALEBreporter.nih.gov
Defining the molecular interactions required for flavivirus genome packaging and virus assemblyNIHNational Institute of Allergy and Infectious Diseases2023 to 2024$771,179August 10, 2023July 31, 2025JOSE, JOYCEreporter.nih.gov
Molecular regulatory mechanism of Zika virus-induced intracranial calcificationsNIHNational Institute of Dental & Craniofacial Research2022 to 2024$746,997May 1, 2022April 30, 2025CHEN, WEIQIANGreporter.nih.gov
Arbovirus Transmission Dynamics Across a Metapopulation Undergoing Environmental and Social ChangeNIHNational Institute of Allergy and Infectious Diseases2025$699,339November 19, 2024October 31, 2029EISENBERG, JOSEPH N. S.reporter.nih.gov
Host Regulation of Flavivirus InfectionNIHNational Institute of Allergy and Infectious Diseases2025$530,385June 6, 2025May 31, 2030GACK, MICHAELA ULRIKEreporter.nih.gov
Discovery and Development of Oral Small-molecule Direct-acting AntiviralsNIHNational Institute of Allergy and Infectious Diseases2025$499,825September 29, 2025September 29, 2026SCARNEO, SCOTTreporter.nih.gov
Development of MS2045 for inhibition of Zika methyltransferaseNIHNational Institute of Allergy and Infectious Diseases2023 to 2024$464,750January 2, 2023December 31, 2024AGGARWAL, ANEEL K.reporter.nih.gov
The mechanism of flaviviral suppression of vitamin A metabolismNIHNational Institute of Allergy and Infectious Diseases2023 to 2024$457,250July 19, 2023June 30, 2025WANG, PENGHUAreporter.nih.gov
Human cutaneous responses to arthropod-mediated viral transmissionNIHNational Institute of Allergy and Infectious Diseases2025$449,625July 8, 2025July 7, 2027DOUAM, FLORIANreporter.nih.gov
Big Data Predictive Phylogenetics with Bayesian LearningNIHNational Institute of Allergy and Infectious Diseases2021 to 2024$425,868June 1, 2020May 31, 2025HOLBROOK, ANDREW JAMESreporter.nih.gov
Functional Role of Pseudouridine on Zika Virus Gene ExpressionNIHNational Institute of Allergy and Infectious Diseases2023 to 2024$422,797June 9, 2023May 31, 2025PAGER, CARA THERESIAreporter.nih.gov
Determinants of acute and persistent Zika virus shedding in semenNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$421,088June 1, 2024April 30, 2027DUGGAL, NISHAreporter.nih.gov
Human Genetic Variation Regulating Cellular Susceptibility to Zika VirusNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$420,757June 1, 2024April 30, 2026KO, DENNIS CHUN-YONEreporter.nih.gov
Developing a Chiropteran model to study the impact of thermal stress on antiviral immunity and inflammatory responsesNIHOffice of the Director, National Institutes of Health2024 to 2025$250,005July 1, 2024June 30, 2029FAGRE, ANNAreporter.nih.gov
MECHANISMS REGULATING BREACH OF BLOOD RETINAL BARRIER UPON ZIKA VIRUS INFECTIONNIHNational Eye Institute2024 to 2025$242,180September 30, 2024August 31, 2026SINGH, SNEHAreporter.nih.gov
Role of Mertk in pathological neurodevelopment in mice with congenital Zika virus infectionNIHNational Institute of Neurological Disorders and Stroke2025$234,359January 15, 2025December 31, 2029AGNER, SHANNON CHRISTINEreporter.nih.gov
Unveiling Mechanisms of ZIKV-Induced Cardiac Dysfunction in a mouse modelNIHNational Institute of Allergy and Infectious Diseases2025$154,500August 13, 2025July 31, 2029TANG, QIYIreporter.nih.gov
Characterizing host proteins that restrict Zika virusNIHNational Institute of Allergy and Infectious Diseases2024 to 2025$83,421August 1, 2024January 31, 2026WILLCOX, ALEXANDRA CLAIBORNEreporter.nih.gov
Novel Antiviral Agents Targeting Zika and Dengue VirusNIHNational Institute of Allergy and Infectious Diseases2025$80,000August 1, 2025July 31, 2027LI, XINreporter.nih.gov
Defining Long Term Neurological Consequences Following Asymptomatic ZIKV InfectionNIHNational Institute of Neurological Disorders and Stroke2025$39,298September 1, 2025August 31, 2028DAPRANO, EVANreporter.nih.gov

Organizations

OrganizationPlaceNIH awardsNIH amountNSF awardsNSF amount
Emory UniversityAtlanta, GA4$13.3 million0$0
University of Texas Med BR GalvestonGalveston, TX3$11.2 million0$0
La Jolla Institute for ImmunologyLa Jolla, CA3$8.5 million0$0
Washington UniversitySaint Louis, MO4$7.7 million0$0
Icahn School of Medicine at Mount SinaiNew York, NY4$7.7 million0$0
University of California-BerkeleyBerkeley, CA2$6.3 million0$0
University of Wisconsin-MadisonMadison, WI2$5.2 million0$0
University of California Los AngelesLos Angeles, CA3$4.4 million0$0
Stanford UniversityStanford, CA1$3.7 million0$0
Albert Einstein College of MedicineBronx, NY1$3.7 million0$0
Henry M. Jackson FDN for the Adv Mil/medBethesda, MD1$3.7 million0$0
University of California-Santa CruzSanta Cruz, CA1$3.6 million0$0
L2 Diagnostics, LLCNew Haven, CT1$2.9 million0$0
University of MinnesotaMinneapolis, MN1$2.9 million0$0
Children's Research InstituteWashington, DC1$2.9 million0$0
University of Puerto Rico Med SciencesSan Juan, PR1$2.7 million0$0
University of WashingtonSeattle, WA3$2.6 million0$0
Univ of North Carolina Chapel HillChapel Hill, NC2$2.4 million0$0
Oregon Health & Science UniversityPortland, OR1$2.3 million0$0
Pennsylvania State Univ University ParkUniversity Park, PA2$2.3 million0$0
University of Maryland BaltimoreBaltimore, MD1$2.3 million0$0
University of ArizonaTucson, AZ1$2.3 million0$0
University of Massachusetts AmherstAmherst, MA1$2.2 million0$0
Rutgers University New BrunswickNew Brunswick, NJ2$2.2 million0$0
University of Michigan at Ann ArborAnn Arbor, MI2$2.1 million0$0
Cleveland Clinic Lerner Com-CwruCleveland, OH3$2.1 million0$0
Virginia Polytechnic Institute and State UniversityBlacksburg, VA2$2 million0$0
University of Missouri-ColumbiaColumbia, MO1$2 million0$0
University of California-RiversideRiverside, CA1$1.9 million0$0
Fred Hutchinson Cancer CenterSeattle, WA1$1.9 million0$0
University of California at DavisDavis, CA1$1.5 million0$0
University of FloridaGainesville, FL1$1.5 million0$0
Vanderbilt University Medical CenterNashville, TN1$1.3 million0$0
Research Triangle InstituteResearch Triangle Park, NC1$1.2 million0$0
University of California, San FranciscoSan Francisco, CA1$1.2 million0$0
Connecticut Agricultural Experiment StaNew Haven, CT1$1.2 million0$0
Ut Southwestern Medical CenterDallas, TX1$919,5360$0
Trustees of Boston UniversityBoston, MA1$808,9190$0
Loyola University ChicagoMaywood, IL1$781,7180$0
Eydis Bio, Inc.Durham, NC1$499,8250$0
University of Connecticut SCH of Med/dntFarmington, CT1$457,2500$0
Boston University Medical CampusBoston, MA1$449,6250$0
SUNY at AlbanyAlbany, NY1$422,7970$0
Duke UniversityDurham, NC1$420,7570$0
Colorado State UniversityFort Collins, CO1$250,0050$0
Wayne State UniversityDetroit, MI1$242,1800$0
Howard UniversityWashington, DC1$154,5000$0
Baylor College of MedicineHouston, TX1$80,0000$0

Funding by fiscal year

Fiscal yearNIH awardsNIH amountNSF awardsNSF amount
202549$31,084,3640$0
202462$34,813,3310$0
202344$25,326,3720$0
202237$22,554,6960$0
202133$20,603,0940$0

Open federal funding opportunities

From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.

Open opportunityNumberAgencyListingClosesAward ceilingWhy it matches
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)RFA-AI-27-002NIH93.855November 10, 2026Not listedSame assistance listing 93.855 as 56 awards here
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)RFA-AI-27-005NIH93.855November 10, 2026Not listedSame assistance listing 93.855 as 56 awards here
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)PAR-25-370NIH93.855November 16, 2026$50,000Same assistance listing 93.855 as 56 awards here
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)PAR-25-369NIH93.855November 18, 2026Not listedSame assistance listing 93.855 as 56 awards here
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)PAR-25-371NIH93.855November 18, 2026Not listedSame assistance listing 93.855 as 56 awards here
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)PAR-25-379NIH93.855January 7, 2027Not listedSame assistance listing 93.855 as 56 awards here
HIV/AIDS Clinical Trials Network Leadership and Operations CentersRFA-AI-28-001NIH93.855January 22, 2027Not listedSame assistance listing 93.855 as 56 awards here
HIV/AIDS Clinical Trials Network Laboratory CentersRFA-AI-28-002NIH93.855January 22, 2027Not listedSame assistance listing 93.855 as 56 awards here
HIV/AIDS Clinical Trials Network Statistical and Data Management CentersRFA-AI-28-003NIH93.855January 22, 2027Not listedSame assistance listing 93.855 as 56 awards here
HIV/AIDS Clinical Trials Network Clinical Trials UnitsRFA-AI-28-004NIH93.855January 22, 2027Not listedSame assistance listing 93.855 as 56 awards here
Precision and Systems Biology to Uncover the Link Between Chronic and Infectious DiseasesRFA-AI-28-014NIH93.855January 22, 2027Not listedSame assistance listing 93.855 as 56 awards here
Immune Tolerance Network (UM1 Clinical Trial Required)RFA-AI-28-005NIH93.855January 29, 2027Not listedSame assistance listing 93.855 as 56 awards here
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)RFA-AI-28-012NIH93.855January 29, 2027Not listedSame assistance listing 93.855 as 56 awards here
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)RFA-AI-28-024NIH93.855February 11, 2027Not listedSame assistance listing 93.855 as 56 awards here
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)RFA-LM-28-001NIH93.855February 11, 2027$775,000Same assistance listing 93.855 as 56 awards here
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)PA-27-100NIH93.855April 5, 2027Not listedSame assistance listing 93.855 as 56 awards here
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)PA-27-102NIH93.855April 5, 2027Not listedSame assistance listing 93.855 as 56 awards here
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)PA-24-176NIH93.855May 7, 2027Not listedSame assistance listing 93.855 as 56 awards here
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)PA-24-185NIH93.855May 7, 2027Not listedSame assistance listing 93.855 as 56 awards here
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required)PA-24-187NIH93.855May 7, 2027Not listedSame assistance listing 93.855 as 56 awards here

Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.